LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,418 | -7.1% | 43,460 | -7.1% | 0.00% | – |
| Q2 2023 | $154,374 | -19.1% | 46,780 | -18.9% | 0.00% | – |
| Q1 2023 | $190,821 | -7.6% | 57,650 | +0.8% | 0.00% | – |
| Q4 2022 | $206,449 | -59.2% | 57,188 | +0.1% | 0.00% | – |
| Q3 2022 | $506,000 | +14.0% | 57,117 | -0.7% | 0.00% | – |
| Q2 2022 | $444,000 | -20.6% | 57,502 | -3.3% | 0.00% | – |
| Q1 2022 | $559,000 | +30.9% | 59,460 | -3.3% | 0.00% | – |
| Q4 2021 | $427,000 | -26.3% | 61,504 | +1.1% | 0.00% | – |
| Q3 2021 | $579,000 | -6.0% | 60,857 | -1.3% | 0.00% | – |
| Q2 2021 | $616,000 | -25.9% | 61,630 | -13.3% | 0.00% | – |
| Q1 2021 | $831,000 | -66.3% | 71,078 | +2.9% | 0.00% | – |
| Q4 2020 | $2,466,000 | +159.6% | 69,061 | +0.6% | 0.00% | – |
| Q3 2020 | $950,000 | -16.7% | 68,661 | -0.6% | 0.00% | – |
| Q2 2020 | $1,140,000 | +125.3% | 69,094 | +16.1% | 0.00% | – |
| Q1 2020 | $506,000 | – | 59,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |